Apnea Test ABG: Critical Component in Brain Death Determination
An apnea test arterial blood gas (ABG) is a mandatory examination for brain death determination that documents the absence of respiratory drive despite an adequate PaCO2 stimulus, requiring a PaCO2 ≥60 mmHg and ≥20 mmHg above baseline with no respiratory effort observed. 1
Purpose and Clinical Significance
- The apnea test is essential for diagnosing brain death as it confirms definitive loss of brainstem function by demonstrating the absence of respiratory drive despite a strong physiological stimulus to breathe 2
- It is one of the core components of brain death determination, along with clinical examination confirming coma, absence of brainstem reflexes, and flaccid tone 1
Prerequisites Before Performing the Test
- Normalization of pH and PaCO2 measured by arterial blood gas analysis 1
- Core temperature maintained above 35°C 1
- Normalization of blood pressure appropriate for patient's age 1
- Correction of any factors that could affect respiratory effort 1
- Adequate preoxygenation with 100% oxygen for 5-10 minutes before initiating the test 1
Technique for Performing the Apnea Test
Preparation phase:
Oxygen delivery methods during test:
Monitoring during the test:
Interpretation of results:
Safety Considerations and Potential Complications
- Hypoxemia (oxygen saturation <85%) 1
- Hemodynamic instability or hypotension 3
- Cardiac arrhythmias 2
- Pneumothorax 2
- Excessive hypercarbia and acidosis 2
Special Circumstances
- If the apnea test cannot be completed safely due to hemodynamic instability, desaturation below 85%, or inability to reach target PaCO2, the patient should be placed back on ventilator support 1
- In such cases, another attempt may be performed later or ancillary studies (EEG, cerebral blood flow studies) should be pursued to assist with brain death determination 1
- For patients with chronic respiratory disease, the PaCO2 should still increase to ≥20 mmHg above their baseline level 1
- For patients on extracorporeal membrane oxygenation (ECMO), modifications to the technique are required, such as decreasing the sweep gas flow to allow CO2 accumulation 4
Common Pitfalls and Caveats
- The rate of PaCO2 increase is variable and unpredictable, ranging from 0.5 to 10.5 mmHg/min 5
- The rate of PaCO2 increase tends to decline throughout the duration of the test, which can lead to unnecessarily prolonged testing 5
- High gas flow rates with tracheal insufflation may promote CO2 washout, preventing adequate PaCO2 rise 1
- Continuous positive airway pressure (CPAP) ventilation during testing may falsely report spontaneous ventilation 1
- For overweight patients or those with hypoxic brain injury due to hanging, maintaining positive end-expiratory pressure (PEEP) during the test may prevent dramatic reductions in PaO2 6
Documentation Requirements
- Complete documentation of the apnea test is required, including baseline ABG values, duration of the test, serial ABG measurements, and absence of respiratory effort 1
- The test must be performed twice as part of the complete brain death determination protocol, with each examination separated by an observation period 1